fluorexon has been researched along with Brittle Bone Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caird, MS; Eddy, MM; Kozloff, KM; Marini, JC; Ominsky, MS; Sinder, BP | 1 |
1 other study(ies) available for fluorexon and Brittle Bone Disease
Article | Year |
---|---|
Sclerostin antibody improves skeletal parameters in a Brtl/+ mouse model of osteogenesis imperfecta.
Topics: Acid Phosphatase; Adaptor Proteins, Signal Transducing; Animals; Antibodies; Biomarkers; Biomechanical Phenomena; Body Weight; Calcification, Physiologic; Disease Models, Animal; Femur; Fluoresceins; Glycoproteins; Intercellular Signaling Peptides and Proteins; Isoenzymes; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Nanotechnology; Organ Size; Osteocalcin; Osteogenesis; Osteogenesis Imperfecta; Tartrate-Resistant Acid Phosphatase; X-Ray Microtomography | 2013 |